Co-Authors
This is a "connection" page, showing publications co-authored by Cristina Tresoldi and Fabio Ciceri.
Connection Strength
0.794
-
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020 08; 217:108509.
Score: 0.222
-
Testosterone in males with COVID-19: A 7-month cohort study. Andrology. 2022 01; 10(1):34-41.
Score: 0.060
-
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia. Biology (Basel). 2021 Aug 05; 10(8).
Score: 0.060
-
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021 05 11; 12(1):2670.
Score: 0.059
-
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J Neurol. 2021 Dec; 268(12):4436-4442.
Score: 0.059
-
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia. J Clin Endocrinol Metab. 2021 04 23; 106(5):1472-1481.
Score: 0.059
-
Severely low testosterone in males with COVID-19: A case-control study. Andrology. 2021 07; 9(4):1043-1052.
Score: 0.058
-
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest. 2020 12 01; 130(12):6366-6378.
Score: 0.057
-
Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
Score: 0.057
-
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia. 2020 12; 63(12):2548-2558.
Score: 0.057
-
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis. Nat Commun. 2017 09 19; 8(1):593.
Score: 0.046